Logo
x

Search

Subscribe Now

bio-thera solutions

Bio-Thera Solutions Expands its Partnership with Pharmapark for BAT2306 (Biosimilar, Cosentyx) Across Russia and Other Countries

Bio-Thera Solutions Expands its Partnership with Pharmapark for BAT2306 (Biosimilar, Cosentyx) Across Russia and Other Countries

  • August 20, 2024
Bio-Thera Solutions Reports the Initiation of Combined P-I/P-III Study of BAT3306 (Biosimilar, Keytruda)

Bio-Thera Solutions Reports the Initiation of Combined P-I/P-III Study of BAT3306 (Biosimilar, Keytruda)

  • July 25, 2024
Bio-Thera Solutions and SteinCares Collaborate for Marketing Biosimilars Across LATAM

Bio-Thera Solutions and SteinCares Collaborate for Marketing Biosimilars Across LATAM

  • March 19, 2024
PharmaShots Weekly Snapshots (October 09–13, 2023) _

PharmaShots Weekly Snapshots (October 09–13, 2023) _

  • October 14, 2023
Bio-Thera Solutions Receives the US FDA’s Approval for Tofidence (biosimilar, tocilizumab)

Bio-Thera Solutions Receives the US FDA’s Approval for Tofidence (biosimilar, tocilizumab)

  • October 9, 2023
Bio-Thera Solutions Demonstrated High Similarity Between BAT1706, a proposed biosimilar of bevacizumab and Reference Bevacizumab

Bio-Thera Solutions Demonstrated High Similarity Between BAT1706, a proposed biosimilar of bevacizumab and Reference Bevacizumab

  • July 27, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.